Schapira AH - Search Results

1

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

Chaudhuri KR, Schapira AH. Chaudhuri KR, et al. Among authors: schapira ah. Lancet Neurol. 2009 May;8(5):464-74. doi: 10.1016/S1474-4422(09)70068-7. Lancet Neurol. 2009. PMID: 19375664 Review.

2

Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Löhle M, Ramberg CJ, Reichmann H, Schapira AH. Löhle M, et al. Among authors: schapira ah. Drugs. 2014 Apr;74(6):645-57. doi: 10.1007/s40265-014-0209-5. Drugs. 2014. PMID: 24756431 Review.

3

Dopamine agonists in Parkinson's disease.

Yamamoto M, Schapira AH. Yamamoto M, et al. Among authors: schapira ah. Expert Rev Neurother. 2008 Apr;8(4):671-7. doi: 10.1586/14737175.8.4.671. Expert Rev Neurother. 2008. PMID: 18416667 Review.

4

Future directions in the treatment of Parkinson's disease.

Schapira AH. Schapira AH. Mov Disord. 2007 Sep;22 Suppl 17:S385-91. doi: 10.1002/mds.21679. Mov Disord. 2007. PMID: 18175401 Review.

5

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Salin L, Juhel N, Poewe W; Pramipexole ER Studies Group. Schapira AH, et al. Neurology. 2011 Aug 23;77(8):767-74. doi: 10.1212/WNL.0b013e31822affdb. Epub 2011 Aug 10. Neurology. 2011. PMID: 21832216 Clinical Trial.

6

Parkinson disease: Parkinson disease clinical subtypes and their implications.

Schapira AH, Schrag A. Schapira AH, et al. Nat Rev Neurol. 2011 May;7(5):247-8. doi: 10.1038/nrneurol.2011.40. Epub 2011 Mar 22. Nat Rev Neurol. 2011. PMID: 21423265 No abstract available.

7

Targeting mitochondria for neuroprotection in Parkinson disease.

Schapira AH, Patel S. Schapira AH, et al. JAMA Neurol. 2014 May;71(5):537-8. doi: 10.1001/jamaneurol.2014.64. JAMA Neurol. 2014. PMID: 24664140 No abstract available.

8

Therapeutic prospects for Parkinson disease.

Olanow CW, Schapira AH. Olanow CW, et al. Among authors: schapira ah. Ann Neurol. 2013 Sep;74(3):337-47. doi: 10.1002/ana.24011. Ann Neurol. 2013. PMID: 24038341 Review.

9

Calcium dysregulation in Parkinson's disease.

Schapira AH. Schapira AH. Brain. 2013 Jul;136(Pt 7):2015-6. doi: 10.1093/brain/awt180. Epub 2013 Jun 20. Brain. 2013. PMID: 23788521 No abstract available.

10

Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

deSouza RM, Moro E, Lang AE, Schapira AH. deSouza RM, et al. Among authors: schapira ah. Ann Neurol. 2013 May;73(5):565-75. doi: 10.1002/ana.23890. Ann Neurol. 2013. PMID: 23483564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results